Managing director Dede Goldschmidt spelled out the unit's investment strategy along with its place in Samsung's corporate VC activities and the state of the post-pandemic market.

With a remit across healthcare, life sciences and advanced materials, Merck’s corporate venturing unit is scoping an opportunity-filled landscape.

Q&A with Victoria Lietha, principal, ABB Technology Ventures

Q&A with Shinichiro Hori, CEO, Z Venture Capital

Q&A with Basil Darwish, managing director, fintech and enterprise IT lead, Wells Fargo Strategic Capital

SEI Ventures is seeking disruptors in the fintech space having expanded from seed-stage deals, according to unit chief Russ Kliman.

Q&A with Harrie Vollaard, managing director, Rabo Frontier Ventures

James Mawson talked to star fund manager, James Anderson from Baillie Gifford as part of the GCV Symposium 2021 about why Britain is not ‘breeding’ more unicorns

Q&A with Fernando Impuesto, general manager; Emilio Martínez, head of open innovation and corporate venturing; and Sergio García, head of venture building, Enagás Emprende

Q&A with Rob Coppedge, CEO, Echo Health Ventures